156
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Cost-Effectiveness of Domiciliary High Flow Nasal Cannula Treatment in COPD Patients with Chronic Respiratory Failure

ORCID Icon, ORCID Icon & ORCID Icon
Pages 553-564 | Published online: 18 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Erik J Groessl, Steven R Tally & Naomi Hillery. (2023) Cost-Effectiveness of Humidified High-Flow Therapy (HHFT) for COPD Patients on Long-Term Oxygen Therapy. ClinicoEconomics and Outcomes Research 15, pages 239-250.
Read now
Richard J Milne, Hans-Ulrich Hockey & Jeffrey Garrett. (2022) Hospital Cost Savings for Sequential COPD Patients Receiving Domiciliary Nasal High Flow Therapy. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1311-1322.
Read now

Articles from other publishers (6)

Maria Laura Vega Pittao, Gioacchino Schifino, Lara Pisani & Stefano Nava. (2023) Home High-Flow Therapy in Patients with Chronic Respiratory Diseases: Physiological Rationale and Clinical Results. Journal of Clinical Medicine 12:7, pages 2663.
Crossref
Patricia S. Bramati, Ahsan Azhar, Rida Khan, Margarita Tovbin, Alex Cooper, Imelda Pangemanan, Bryan Fellman & Eduardo Bruera. (2023) High Flow Nasal Cannula in Patients With Cancer at the End of Life. Journal of Pain and Symptom Management 65:4, pages e369-e373.
Crossref
Manel Luján. (2023) Home High-Flow Oxygen Therapy Should Be Considered in Patients With COPD and Chronic Respiratory Failure. Archivos de Bronconeumología 59:1, pages 5-6.
Crossref
Yi Wang, Yong Jie Ding & Qing Yun Li. (2022) High-flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: Just Good Enough?. American Journal of Respiratory and Critical Care Medicine 206:11, pages 1433-1434.
Crossref
Ulla Møller Weinreich, Charlotte Burchardt & Jasmina Huremovic. (2022) The effect of domiciliary high flow nasal cannula treatment on dyspnea and walking distance in patients with interstitial lung disease – A pilot study. Chronic Respiratory Disease 19, pages 147997312211370.
Crossref
. (2021) High-flow nasal cannula cost effective in chronic respiratory failure. PharmacoEconomics & Outcomes News 882:1, pages 15-15.
Crossref